Understanding and Treating Female Sexual Dysfunction

FEATURING:

Anita H. Clayton, MD
Sheryl A. Kingsberg, Ph.D
Chief, Division of Behavioral Medicine, Department of OB/GYN, MacDonald Women's Hospital
University Hospitals Cleveland Medical Center
Professor, Departments of Reproductive Biology and Psychiatry
Case Western Reserve University School of Medicine
James A Simon, MD

 James A. Simon, MD, CCD, NCMP, IF, FACOG
Clinical Professor, George Washington University Women's Health & Research Consultants®
Washington, DC

LEARNING OBJECTIVES:

Upon completion of this activity, the participant should be able to:

  • Discuss treatment options for women with female sexual dysfunction, including the first available medication for a specific type of female sexual dysfunction
  • Discuss the prevalence of female sexual dysfunction and counseling programs
  • Evaluate the differences in definitions, severity criteria, and duration of disease for female sexual dysfunction as published in DSM-5


A CME activity provided by Evolve Medical Education LLC

Supported through an educational grant from Valeant Pharmaceuticals International.

Evolve Logo

Female sexual dysfunction (FSD) is an overall umbrella disease that may affect as many as 40 million women in the U.S., with prevalence rates cited from 30% to as high as 80%. The etiology of FSD, however, is less well-defined or understood. Comprising both physiological and psychological aspects, FSD can manifest in a variety of ways. This educational activity will include discussions on the definition, prevalence, diagnosis and related guidelines for managing this disease state.

Tuesday, October 3, 2017 | 8PM EDT


ACCREDITATION STATEMENT
Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT
Evolve Medical Education LLC designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with their participation in the activity.

GRANTOR STATEMENT
This continuing medical education activity is supported through an unrestricted educational grant from Valeant Pharmaceuticals International.